Make your money go further for just 25p per day

OptiBiotix Health plc (AIM: OPTI) – further contract signed with NIZO Food Research

10/03/2015 · OptiBiotix Health PLC (OPTI) 

Today OptiBiotix, a life sciences business, has announced that it has signed a third agreement with NIZO Food Research BV ("NIZO"), the contract food research organisation based in the Netherlands.

We reported on OptiBiotix last week, it is a very exciting new business operating in one of the most progressive areas of biotechnological research. It aims to develop compounds which modify the human microbiome to help combat obesity, diabetes and high cholesterol.

Using its technology platforms for microbiome modulation, the Group has generated three research programmes which they are developing in the functional foods and health supplements marketplace.

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on OptiBiotix Health PLC

The Good, Bad and Ugly from AIM this week

18/09/2015 · Company Insights
With results season in full flow and some great numbers issued from many AIM companies…

A year of tremendous progress for this fascinating company – one of our top selections of 2015

17/09/2015 · Company Insights
In March 2015, we reported on OptiBiotix Health, an exciting company specialising in biotechnological research. It…

More Company Insights

Rocketing share price

Stonking Small Cap: still on the fast track!

24/04/2024

Poorly worded | Sector winner | Improving returns

Sign-up to our free email updates

SIGN UP